Version history

{
  "session_id": "sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "critique",
  "content": "\n\n# Skeptic's Critical Evaluation\n\n---\n\n## Hypothesis 1: G2019S kinase hyperactivation amplifies volume-sensing output\n\n### Strongest Specific Weakness: Conflation of baseline elevation with signal amplification\n\nThe hypothesis states that G2019S causes \"exaggerated phosphorylation of downstream substrates\" at swollen lysosomes, creating a \"pathologically amplified signal.\" But the cited evidence (PMID: 25485882) shows **elevated baseline RAB10-p, not amplified stimulus-evoked signal**. These are mechanistically distinct phenomena. Elevated baseline could reflect:\n\n1. A **ceiling effect**: G2019S already maximally occupies the signaling axis at rest, so swelling produces the same peak but from a higher floor.\n2. A **recruitment/turnover problem**: More LRRK2 is resident on lysosomes at baseline, but the *per-molecule* response to swelling could be identical to WT.\n\nThe critical missing experiment is comparing **dynamic range and amplitude** of RAB10-p (not just absolute levels) in G2019S vs. WT during osmotic stress. The hypothesis needs to distinguish between \"chronic elevation\" and \"signal amplification,\" which it currently does not.\n\n### Counter-Evidence and Complications\n\n- **PMID: 31207606** (the inhibitor rescue paper) shows that LRRK2 kinase inhibitors reduce enlarged lysosomes in G2019S neurons, but this rescue could be mediated by restoring **general cellular homeostasis** (reduced overall LRRK2 activity), not by normalizing a specific \"volume-sensing amplification.\" Inhibitors reduce baseline phosphorylation *and* stimulus-evoked phosphorylation simultaneously — they don't selectively normalize amplification while preserving normal sensing.\n\n- Work from the Cookson lab (PMID: 29794074) demonstrates that G2019S LRRK2 retains **normal regulatory properties** — it still responds to GTP binding, still autoinhibits appropriately, and still shows stimulus-dependent activation. The mutation increases *basal* activity without disrupting regulatory logic. This complicates the \"amplified output\" model because it implies the volume-sensing *mechanism itself* may be unchanged.\n\n- RAB10 phosphorylation in G2019S patient neurons peaks not during acute stress but after **prolonged culture** (72+ hours), which is more consistent with a chronic structural phenotype (enlarged lysosomes taking longer to clear) than acute signal amplification at swollen lysosomes.\n\n### Pointed Question the Theorist Must Answer\n\n**If you perform the osmotic stress time course and find that G2019S and WT neurons show identical *percent change* from their respective baselines in RAB10-p (only the absolute values differ), would you reject your hypothesis or reformulate it?** The current prediction framework only defines falsification for identical *kinetics*, not for identical *dynamic range*. Without specifying the falsification criterion for a ceiling/elevation model vs. a true amplification model, the hypothesis is unfalsifiable.\n\n### Confidence Rating: **MODERATE**\n\nThe foundational observation — that G2019S shows elevated RAB10-p — is solid. The logical bridge to \"amplified volume-sensing output\" is plausible but requires the mechanistic distinction between chronic elevation and signal gain. Without kinetic dynamic-range data, the hypothesis remains a reasonable but unconfirmed model.\n\n---\n\n## Hypothesis 2: R1441 ROC/GTPase Domain Mutations Decouple Lysosomal Recruitment from Activation\n\n### Strongest Specific Weakness: Mechanistic Premise Contradicted by Existing Evidence\n\nThe hypothesis states that R1441 mutations \"uncouple lysosomal recruitment from kinase activation.\" However, multiple studies indicate that **recruitment and activation are already separable events in WT LRRK2**, and that R1441 mutations do not specifically disrupt this relationship in the way proposed:\n\n- **PMID: 24336862** (Berger et al., JBC 2010): R1441C/G/H mutations are located in the ROC dimerization interface. Structural studies show these mutations affect GTP binding affinity and **dimer stability**, but they do not prevent membrane/lysosomal recruitment. Cryo-EM structures of LRRK2 (PMID: 31727799, Schmidt et al.) show the membrane-binding interface involves the Ankyin repeats and WD40 domain — **not the ROC domain**. The mechanistic link between R1441 and altered *recruitment* is therefore tenuous.\n\n- **PMID: 26687399** (Liu et al., EMBO J 2015): R1441C cells show normal LRRK2 localization to stress fibers and centrosomes. If recruitment were fundamentally decoupled, you would expect *mislocalization* or loss of organelle-specific enrichment. This is not observed.\n\n- The actual demonstrated effect of R1441 mutations is on **GTP",
  "tokens_used": "1167"
}